Therapeutic use of recombinant human G-CSF (rhG-CSF) in a canine model of sublethal and lethal whole-body irradiation.
about
Vitamin E Analogs as Radiation Response Modifiers5-AED enhances survival of irradiated mice in a G-CSF-dependent manner, stimulates innate immune cell function, reduces radiation-induced DNA damage and induces genes that modulate cell cycle progression and apoptosisVitamin E: tocopherols and tocotrienols as potential radiation countermeasuresFilgrastim improves survival in lethally irradiated nonhuman primatesAdipose-Derived Mesenchymal Stem Cells (ADSCs) With the Potential to Ameliorate Platelet Recovery, Enhance Megakaryopoiesis, and Inhibit Apoptosis of Bone Marrow Cells in a Mouse Model of Radiation-Induced Thrombocytopenia.THE POTENTIATION OF THE RADIOPROTECTIVE EFFICACY OF TWO MEDICAL COUNTERMEASURES, GAMMA-TOCOTRIENOL AND AMIFOSTINE, BY A COMBINATION PROPHYLACTIC MODALITY.Animal models for medical countermeasures to radiation exposure.Cytokines and progenitor cells of granulocytopoiesis in peripheral blood of patients with bacterial infections.Radiation countermeasure agents: an update (2011-2014)Establishing a murine model of the hematopoietic syndrome of the acute radiation syndromePEGylated G-CSF (BBT-015), GM-CSF (BBT-007), and IL-11 (BBT-059) analogs enhance survival and hematopoietic cell recovery in a mouse model of the hematopoietic syndrome of the acute radiation syndrome.Survival efficacy of the PEGylated G-CSFs Maxy-G34 and neulasta in a mouse model of lethal H-ARS, and residual bone marrow damage in treated survivors.Combined administration of recombinant human megakaryocyte growth and development factor and granulocyte colony-stimulating factor enhances multilineage hematopoietic reconstitution in nonhuman primates after radiation-induced marrow aplasia.A nonhuman primate model of the hematopoietic acute radiation syndrome plus medical management.Radioprotection.History and development of radiation-protective agents.Radiation victim management and the haematologist in the future: time to revisit therapeutic guidelines?A review of radiation countermeasure work ongoing at the Armed Forces Radiobiology Research Institute.Granulocyte colony-stimulating factor in the treatment of acute radiation syndrome: a concise review.Animal models for acute radiation syndrome drug discovery.A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part I. Radiation sub-syndromes, animal models and FDA-approved countermeasures.Evaluation of immunomodulatory effect of recombinant human granulocyte-macrophage colony-stimulating factor on polymorphonuclear cell from dogs with cancer in vitro.Combined Therapy of Pegylated G-CSF and Alxn4100TPO Improves Survival and Mitigates Acute Radiation Syndrome after Whole-Body Ionizing Irradiation alone and Followed by Wound Trauma.Haematopoietic growth factors in the treatment of therapeutic and accidental irradiation-induced bone marrow aplasia.Clinical and pathological findings in dogs following supralethal total body irradiation with and without infusion of autologous long-term marrow culture cells.Activation of adenosine A(3) receptors supports hematopoiesis-stimulating effects of granulocyte colony-stimulating factor in sublethally irradiated mice.Effects of whole-body gamma irradiation and 5-androstenediol administration on serum G-CSF.Haemopoietic injury after irradiation: analysis of dose responses and repair using a target-cell model.An oral HemokineTM, α-methylhydrocinnamate, enhances myeloid and neutrophil recovery following irradiation in vivo.
P2860
Q26781114-26ADFDC8-3DB1-4609-90BE-D89DDFEB68FAQ28272017-457F908D-E3A9-4BEC-BE5D-4F123E0C8B2EQ28290335-00D45877-FB39-4626-98F3-243CFEDD93B1Q33390547-79D19C60-1C96-4DDC-8B3D-DFF342D6195CQ33422819-E3780810-962D-40D1-8A1B-BA37EB36C922Q33728050-CFFA3FDB-447A-4D4F-82F3-C8CECDAC25EDQ34491137-8EB31156-B284-4E6C-8C57-AD832707D148Q35378321-79A62062-B6C5-409C-9EF0-83E6F3BC8610Q35626587-71844F3A-782A-4287-8FBC-7B0BF6341214Q37094589-E83EB1DA-01DD-45F3-80A6-504BD8C92C2AQ37349170-403DA07A-A655-4A72-BD72-EC601E4AF5ACQ37349188-79802A55-FCAD-482D-88EE-AB79CA44E919Q37354699-4A51CF16-CCD2-41CD-809A-FBE04D484494Q37424451-C98E4A71-7145-4D1D-A4AF-F812633FFAABQ37469646-EF6651F7-7AAF-450B-AAEF-8B9AA94DE575Q37532178-165F3387-A34E-452C-9463-2E07DA36AEABQ37769565-A6B62525-E4F9-4079-BDD7-EA0910467A80Q37970729-06A4C0D9-7C33-4D7A-8D3F-B54211A6C605Q38205372-B45C2EA2-B512-4244-B600-7366DAD7040CQ38394740-97893972-553B-4D1A-8A47-EC4CDC10CE82Q39398444-6EA4518E-77DC-4EAD-A378-A8BC1A61A754Q39835753-F2E49163-B71F-4D6D-9841-81EDB696FE85Q40076209-FD408E5B-013A-4630-897B-C2C3BCF94A1AQ40398495-852C807C-18CE-4B3B-858B-FCEBC0BD96B2Q42053431-DBD28C14-8A83-4CDB-9F59-B49896194A17Q43002320-43326F3C-DAA3-460C-9D33-019B5CA70A9CQ46910828-50101CBC-AE8B-408A-841C-9A9B45FD7361Q52253173-B596C250-27D7-46D1-9F01-B1E2295711ECQ52820544-2DA7F8BD-9EFB-40FF-9B3B-8E79DB958FD9
P2860
Therapeutic use of recombinant human G-CSF (rhG-CSF) in a canine model of sublethal and lethal whole-body irradiation.
description
1990 nî lūn-bûn
@nan
1990 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Therapeutic use of recombinant ...... lethal whole-body irradiation.
@ast
Therapeutic use of recombinant ...... lethal whole-body irradiation.
@en
type
label
Therapeutic use of recombinant ...... lethal whole-body irradiation.
@ast
Therapeutic use of recombinant ...... lethal whole-body irradiation.
@en
prefLabel
Therapeutic use of recombinant ...... lethal whole-body irradiation.
@ast
Therapeutic use of recombinant ...... lethal whole-body irradiation.
@en
P2093
P2860
P1476
Therapeutic use of recombinant ...... lethal whole-body irradiation.
@en
P2093
MacVittie TJ
Patchen ML
P2860
P304
P356
10.1080/09553009014550891
P577
1990-04-01T00:00:00Z